# Halozyme Therapeutics, Inc. (HALO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/HALO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 857.71M | $ 379.96M | $ 413.06M | $ 2.15B | $ 143.54M |
| 2025 | $ 1.43B | $ 324.47M | $ 660.00M | $ 2.14B | $ 48.81M |
| 2024 | $ 1.07B | $ 466.77M | $ 492.29M | $ 1.51B | $ 363.82M |
| 2023 | $ 896.63M | $ 304.47M | $ 403.61M | $ 1.50B | $ 83.81M |
| 2022 | $ 737.42M | $ 225.80M | $ 262.86M | $ 1.51B | $ 169.80M |
| 2021 | $ 526.94M | $ 478.68M | $ 354.20M | $ 876.67M | $ 196.95M |
| 2020 | $ 340.90M | $ 164.45M | $ 67.45M | $ 397.23M | $ 151.05M |
| 2019 | $ 252.98M | $ -93.24M | $ -115.47M | $ 402.59M | $ 91.77M |
| 2018 | $ 200.56M | $ -106.09M | $ -71.53M | $ 126.38M | $ 248.89M |
| 2017 | $ 426.52M | $ 84.83M | $ 178.77M | $ 202.35M | $ 208.37M |
| 2016 | $ 201.82M | $ -141.74M | $ -73.63M | $ 216.62M | $ -32.48M |
| 2015 | $ 189.63M | $ -45.25M | $ -55.38M | $ 49.83M | $ 43.00M |
| 2014 | $ 106.45M | $ -96.61M | $ -69.08M | $ 49.86M | $ 41.35M |
| 2013 | $ 77.94M | $ -118.73M | $ -73.44M | $ 49.77M | $ -19.99M |
| 2012 | $ 61.11M | $ -77.32M | $ -94.01M | $ 31.11M | $ 48.85M |
| 2011 | $ 82.40M | $ -29.05M | $ -51.68M | $ 0 | $ 10.90M |
| 2010 | $ 20.63M | $ -80.62M | $ -69.70M | $ 0 | $ 20.35M |
| 2009 | $ 20.70M | $ -88.37M | $ -63.00M | $ 0 | $ 6.90M |
| 2008 | $ 13.27M | $ -73.67M | $ -55.32M | $ 0 | $ 15.38M |
| 2007 | $ 5.75M | $ -36.18M | $ -3.81M | $ 0 | $ 57.77M |
| 2006 | $ 1.49M | $ -22.34M | $ 10.17M | $ 0 | $ 23.08M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 14.95 |
| Liabilities / Eq | 16.96 |
| Current Ratio | 2.71 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 9.97 |
| Gross Debt / FCF | 8.22 |

## Other views

- [Metrics](https://sponda.capital/en/HALO.md)
- [Charts](https://sponda.capital/en/HALO/charts.md)
- [Compare](https://sponda.capital/en/HALO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.